$STRM
STREAMLINE HEALTH SOLUTIONS INC. Stock $strm

$strm Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000149315223013852 Filed on April 27, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$5.332M	$6.745M	$24.89M
YoY Change	-10.16%	11.56%	43.21%
Cost Of Revenue	$2.786M	$8.404M	$13.40M
YoY Change	-13.18%	172.77%	56.17%
Gross Profit	$2.546M	-$1.659M	$11.49M
YoY Change	-6.6%	-155.95%	30.58%
Gross Profit Margin	47.75%	-24.6%	46.18%
Selling, General & Admin	$3.806M	$3.646M	$16.13M
YoY Change	-15.44%	6.48%	35.23%
% of Gross Profit	149.49%		140.37%
Research & Development	$1.701M	$1.515M	$6.042M
YoY Change	129747.33%	0.87%	26.35%
% of Gross Profit	66.81%		52.57%
Depreciation & Amortization	$1.059M	$4.273M	$54.00K
YoY Change	9.06%	330.31%	-98.31%
% of Gross Profit	41.59%		0.47%
Operating Expenses	$5.507M	$169.0K	$22.18M
YoY Change	-5.26%	-96.57%	32.69%
Operating Profit	-$2.996M	-$1.828M	-$10.83M
YoY Change	-2.95%	-6.78%	36.91%
Interest Expense	$248.0K	-$230.0K	$749.0K
YoY Change	-287.88%	78.29%	-417.37%
% of Operating Profit
Other Income/Expense, Net	$32.00K	$50.00K	$201.0K
YoY Change	-94.0%	-97.86%	-89.48%
Pretax Income	-$2.848M	-$2.133M	-$11.31M
YoY Change	2.59%	-2321.88%	66.1%
Income Tax	$53.00K	$49.00K	$71.00K
% Of Pretax Income
Net Earnings	-$2.901M	-$2.182M	-$11.38M
YoY Change	4.09%	7173.33%	73.94%
Net Earnings / Revenue	-54.41%	-32.35%	-45.72%
Basic Earnings Per Share	-$0.05		-$0.23
Diluted Earnings Per Share	-$0.05	-$0.04	-$0.23
COMMON SHARES
Basic Shares Outstanding	58.61M shares		49.32M shares
Diluted Shares Outstanding	55.97M shares		49.32M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.987M	$6.598M	$6.598M
YoY Change	-24.74%	-33.25%	-33.25%
Cash & Equivalents	$5.987M	$6.598M	$6.598M
Short-Term Investments
Other Short-Term Assets	$717.0K	$710.0K	$710.0K
YoY Change	69.5%	25.0%	25.0%
Inventory
Prepaid Expenses
Receivables	$4.280M	$7.719M	$7.719M
Other Receivables	$535.0K	$960.0K	$960.0K
Total Short-Term Assets	$11.52M	$15.99M	$15.99M
YoY Change	-15.97%	5.74%	5.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$99.00K	$111.0K	$111.0K
YoY Change	-64.89%	-67.45%	-67.45%
Goodwill	$23.09M	$23.09M
YoY Change		0.0%
Intangibles	$14.34M	$14.79M
YoY Change		-11.75%
Long-Term Investments
YoY Change
Other Assets	$1.598M	$1.695M	$1.695M
YoY Change	59.48%	78.8%	78.8%
Total Long-Term Assets	$44.97M	$45.53M	$45.53M
YoY Change	-2.78%	-2.49%	-2.49%
TOTAL ASSETS
Total Short-Term Assets	$11.52M	$15.99M	$15.99M
Total Long-Term Assets	$44.97M	$45.53M	$45.53M
Total Assets	$56.49M	$61.52M	$61.52M
YoY Change	-5.8%	-0.48%	-0.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$299.0K	$626.0K	$626.0K
YoY Change	-70.48%	-19.54%	-19.54%
Accrued Expenses	$2.505M	$3.265M	$3.300M
YoY Change	-11.89%	62.68%	64.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$875.0K	$750.0K	$750.0K
YoY Change	133.33%	200.0%	200.0%
Total Short-Term Liabilities	$14.44M	$16.78M	$16.77M
YoY Change	-3.81%	24.25%	24.25%
LONG-TERM LIABILITIES
Long-Term Debt	$8.742M	$8.964M	$8.964M
YoY Change	-8.45%	-7.15%	-7.15%
Other Long-Term Liabilities	$143.0K	$104.0K	$271.0K
YoY Change	-96.39%	-97.75%	-94.13%
Total Long-Term Liabilities	$8.989M	$9.235M	$9.235M
YoY Change	-33.48%	-4.34%	-35.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.44M	$16.78M	$16.77M
Total Long-Term Liabilities	$8.989M	$9.235M	$9.235M
Total Liabilities	$23.42M	$26.01M	$26.01M
YoY Change	-17.87%	-6.34%	-6.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.90M	-$97.04M
YoY Change		13.28%
Common Stock	$133.0M	$132.5M
YoY Change		10.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.06M	$35.51M	$35.51M
YoY Change
Total Liabilities & Shareholders Equity	$56.49M	$61.52M	$61.52M
YoY Change	-5.8%	-0.48%	-0.48%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$2.901M	-$2.182M	-$11.38M
YoY Change	4.09%	7173.33%	73.94%
Depreciation, Depletion And Amortization	$1.059M	$4.273M	$54.00K
YoY Change	9.06%	330.31%	-98.31%
Cash From Operating Activities	$126.0K	-$2.422M	-$7.143M
YoY Change	-109.92%	-2262.5%	103.85%
INVESTING ACTIVITIES
Capital Expenditures	$29.00K	$490.0K	$10.00K
YoY Change	-105.59%	-213.16%	-100.67%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$433.0K	-$490.0K	-$1.935M
YoY Change	-16.57%	-10.75%	-85.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$8.316M
YoY Change
Debt Paid & Issued, Net	$125.0K		$250.0K
YoY Change
Cash From Financing Activities	-$304.0K	-2.189M	$5.791M
YoY Change	115.6%	2416.09%	-76.02%
NET CHANGE
Cash From Operating Activities	$126.0K	-2.422M	-7.143M
Cash From Investing Activities	-$433.0K	-490.0K	-$1.935M
Cash From Financing Activities	-$304.0K	-2.189M	$5.791M
Net Change In Cash	-$611.0K	-5.101M	-$3.287M
YoY Change	-68.34%	873.47%	-143.97%
FREE CASH FLOW
Cash From Operating Activities	$126.0K	-$2.422M	-$7.143M
Capital Expenditures	$29.00K	$490.0K	$10.00K
Free Cash Flow	$97.00K	-$2.912M	-$7.153M
YoY Change	-112.92%	-634.31%	256.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	STRM	Effect Of Dilutive Securities Stock Options Restricted Stocks EffectOfDilutiveSecuritiesStockOptionsRestrictedStocks	458335	shares
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001008586
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2023Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations		usd
CY2023Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest		usd
CY2023	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax		usd
CY2023	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	STRM	Forgiveness Of Ppp Loan ForgivenessOfPppLoan		usd
CY2023	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
CY2023	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments		usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities		usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
CY2023	STRM	Proceeds From Term Loan Payable ProceedsFromTermLoanPayable		usd
CY2023	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest		usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense		usd
CY2022	STRM	Capitalized Software Purchased With Stock CapitalizedSoftwarePurchasedWithStock		usd
CY2023	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted		usd
CY2023	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2023	STRM	Effect Of Dilutive Securities Stock Options Restricted Stocks EffectOfDilutiveSecuritiesStockOptionsRestrictedStocks		shares
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	STRM	Income Tax Reconciliation Income Tax Expense Permanent Items Ppp Loan IncomeTaxReconciliationIncomeTaxExpensePermanentItemsPppLoan		usd
CY2022Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets		usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions		usd
CY2023	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-01-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-28132
CY2023	dei	Entity Registrant Name EntityRegistrantName	STREAMLINE HEALTH SOLUTIONS, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-1455414
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	2400 Old Milton Pkwy.
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Box 1353
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Alpharetta
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30009
CY2023	dei	City Area Code CityAreaCode	(888)
CY2023	dei	Local Phone Number LocalPhoneNumber	997-8732
CY2023	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2023	dei	Trading Symbol TradingSymbol	STRM
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	55069915	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58610540	shares
CY2023	dei	Auditor Name AuditorName	FORVIS, LLP
CY2023	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6598000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9885000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	132000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	76000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7719000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3823000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	960000	usd
CY2022Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	843000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	710000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	568000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	15987000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	15119000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	246000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	192000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	79000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	123000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	218000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6224000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	5202000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5846000	usd
CY2022Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5555000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2627000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5121000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14793000	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	16763000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	23089000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	23089000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1695000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	948000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	45534000	usd
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	46696000	usd
CY2023Q1	us-gaap	Assets Assets	61521000	usd
CY2022Q1	us-gaap	Assets Assets	61815000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	626000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	778000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3265000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1803000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	750000	usd
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	250000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	8361000	usd
CY2022Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5794000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	204000	usd
CY2023Q1	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	3738000	usd
CY2022Q1	us-gaap	Asset Acquisition Contingent Consideration Liability Current AssetAcquisitionContingentConsiderationLiabilityCurrent	4672000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	16775000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13501000	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	8964000	usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	9654000	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	167000	usd
CY2022Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	136000	usd
CY2022Q1	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	33000	usd
CY2022Q1	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	4161000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	104000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	286000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	9235000	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14270000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	26010000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	27771000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	10908000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57567210	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57567210	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47840950	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47840950	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	576000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	478000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	131973000	usd
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	119225000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97038000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85659000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	35511000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34044000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61521000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61815000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24889000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17379000	usd
CY2023	STRM	Cost Of Software As Service CostOfSoftwareAsService	6358000	usd
CY2022	STRM	Cost Of Software As Service CostOfSoftwareAsService	3417000	usd
CY2023	STRM	Cost Of Maintenance And Support CostOfMaintenanceAndSupport	427000	usd
CY2022	STRM	Cost Of Maintenance And Support CostOfMaintenanceAndSupport	334000	usd
CY2023	STRM	Cost Of Professional Fees And Licenses CostOfProfessionalFeesAndLicenses	6610000	usd
CY2022	STRM	Cost Of Professional Fees And Licenses CostOfProfessionalFeesAndLicenses	4826000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	16134000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11931000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6042000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4782000	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	149000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2856000	usd
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	35720000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	28146000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-10831000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-10767000	usd
CY2023	us-gaap	Interest Expense InterestExpense	749000	usd
CY2022	us-gaap	Interest Expense InterestExpense	236000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-43000	usd
CY2023	STRM	Acquisition Earnout Valuation Adjustments AcquisitionEarnoutValuationAdjustments	71000	usd
CY2022	STRM	Acquisition Earnout Valuation Adjustments AcquisitionEarnoutValuationAdjustments	1851000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	201000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	60000	usd
CY2022	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest	2327000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11308000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6808000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	109000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11379000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6917000	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	401000	usd
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	26000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	375000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11379000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-6542000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.23
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.16
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49324858	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42815239	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.23
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.16
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49324858	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43273574	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	17489000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22654000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-1313000	usd
CY2022	STRM	Surrender Of Stock During Period Value SurrenderOfStockDuringPeriodValue	-464000	usd
CY2022	STRM	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensation	2216000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-6542000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34044000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	34044000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11328000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-52000	usd
CY2023	STRM	Surrender Of Stock During Period Value SurrenderOfStockDuringPeriodValue	-197000	usd
CY2023	STRM	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensation	1761000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11379000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11379000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	35511000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	35511000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11379000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-6542000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	375000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11379000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6917000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4313000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3697000	usd
CY2023	STRM	Acquisition Earnout Valuation Adjustments AcquisitionEarnoutValuationAdjustments	71000	usd
CY2022	STRM	Acquisition Earnout Valuation Adjustments AcquisitionEarnoutValuationAdjustments	1851000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-43000	usd
CY2023	STRM	Provision For Deferred Income Taxes ProvisionForDeferredIncomeTaxes	9000	usd
CY2022	STRM	Provision For Deferred Income Taxes ProvisionForDeferredIncomeTaxes	95000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1680000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2216000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	189000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11000	usd
CY2022	STRM	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	2327000	usd
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	4202000	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	129000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1197000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	346000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-152000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	17000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1069000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	533000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2598000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1074000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7143000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3884000	usd
CY2022	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	380000	usd
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	12470000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	800000	usd
CY2023	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1925000	usd
CY2022	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1458000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1935000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13169000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8316000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16100000	usd
CY2023	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	2012000	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	52000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1313000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	250000	usd
CY2022	STRM	Proceeds From Term Loan Payable ProceedsFromTermLoanPayable	10000000	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	197000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	464000	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	20000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	168000	usd
CY2023	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	6000	usd
CY2022	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-6000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5791000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24149000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3287000	usd
CY2023	us-gaap	Depreciation Depreciation	54000	usd
CY2022	us-gaap	Depreciation Depreciation	68000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7476000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9885000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2409000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6598000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9885000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	651000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	153000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	21000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_z4xdzX8FfFa2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zGFlYfvNZy8j">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates and judgments, including those related to the recognition of revenue, stock-based compensation, capitalization of software development costs, intangible assets, the allowance for doubtful accounts, contingent consideration and income taxes. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	STRM	Depreciation Fixed Asset DepreciationFixedAsset	198000	usd
CY2022	STRM	Forgiveness Of Ppp Loan And Accrued Interest ForgivenessOfPppLoanAndAccruedInterest	2327000	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	3012000	usd
CY2023	STRM	Capitalized Software Purchased With Stock CapitalizedSoftwarePurchasedWithStock	81000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2079000	usd
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	803000	usd
CY2023Q1	us-gaap	Accrued Exchange Fee Rebate Current And Noncurrent AccruedExchangeFeeRebateCurrentAndNoncurrent	294000	usd
CY2022Q1	us-gaap	Accrued Exchange Fee Rebate Current And Noncurrent AccruedExchangeFeeRebateCurrentAndNoncurrent	283000	usd
CY2023Q1	STRM	Third Partylicense ThirdPartylicense	285000	usd
CY2022Q1	STRM	Third Partylicense ThirdPartylicense	77000	usd
CY2023Q1	STRM	Concession Accrual Amount ConcessionAccrualAmount	226000	usd
CY2022Q1	STRM	Concession Accrual Amount ConcessionAccrualAmount	152000	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	331000	usd
CY2022Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	460000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	50000	usd
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	28000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3265000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1803000	usd
CY2023Q1	STRM	Concession Accrual Amount ConcessionAccrualAmount	226000	usd
CY2022Q1	STRM	Concession Accrual Amount ConcessionAccrualAmount	152000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	84000	usd
CY2023	STRM	Amortized And Abandoned Assets AmortizedAndAbandonedAssets	694000	usd
CY2023	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2423000	usd
CY2022	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	2173000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6042000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4782000	usd
CY2023Q1	STRM	Acquisition Earnout Liability Fair Value AcquisitionEarnoutLiabilityFairValue	3738000	usd
CY2022Q1	STRM	Acquisition Earnout Liability Fair Value AcquisitionEarnoutLiabilityFairValue	8833000	usd
CY2023	STRM	Acquisition Earnout Liability Change In Valuation AcquisitionEarnoutLiabilityChangeInValuation	5095000	usd
CY2023	STRM	Acquisition Payment AcquisitionPayment	5024000	usd
CY2023	STRM	Acquisition Payment Recognized AcquisitionPaymentRecognized	71000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.015	pure
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-11379000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.065	pure
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	194000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24889000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17379000	usd
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	5636000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	25070000	usd
CY2023	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation	the Company expects to recognize approximately 73% over the next 12 months and the remainder thereafter.
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	94000	usd
CY2022Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	125000	usd
CY2023Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	176000	usd
CY2022Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	93000	usd
CY2023	STRM	Deferred Costs Amortization Expenses DeferredCostsAmortizationExpenses	83000	usd
CY2022	STRM	Deferred Costs Amortization Expenses DeferredCostsAmortizationExpenses	110000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zITO16cI3OMa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zjB48vq62EM6">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially expose the Company to concentrations of credit risk, consist primarily of accounts receivable. The Company’s accounts receivable are concentrated in the healthcare industry. However, the Company’s clients typically are well-established hospitals, medical facilities or major health information systems companies with good credit histories that resell the Company’s solutions. Payments from clients have been received within normal time frames for the industry. However, some hospitals and medical facilities have experienced significant operating losses as a result of limits on third-party reimbursements from insurance companies and governmental entities and extended payment of receivables from these entities is not uncommon.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To date, the Company has relied on a limited number of clients and remarketing partners for a substantial portion of its total revenues. The Company expects that a significant portion of its future revenues will continue to be generated by a limited number of clients and its remarketing partners.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	197000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	464000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11379000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6917000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.23
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.16
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	375000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-6917000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.23
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.16
CY2022	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	375000	usd
CY2022	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11379000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-6542000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49324858	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	42815239	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49324858	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43273574	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	149000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2856000	usd
CY2022	STRM	Business Combination Executive Bonuses BusinessCombinationExecutiveBonuses	705000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	850000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	194000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	195000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	36000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	36000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	35000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9750000	usd
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	10000000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	36000	usd
CY2022Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	96000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	9714000	usd
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	9904000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	750000	usd
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	250000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8964000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9654000	usd
CY2021Q2	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	2301000	usd
CY2021Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	26000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	17420000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2627000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14793000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	21884000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5121000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16763000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1971000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1281000	usd
CY2023Q1	STRM	Finite Lived Intangible Assets Amortization Expense Current Year FiniteLivedIntangibleAssetsAmortizationExpenseCurrentYear	1801000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1801000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1801000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1801000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1801000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	5788000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14793000	usd
CY2023	STRM	Amortization Of Intangible Assets Wrote Off Fully AmortizationOfIntangibleAssetsWroteOffFully	4464000	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-62000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-14000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-62000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-14000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-6000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-80000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-15000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-95000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	109000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2390000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1430000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	52000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	26000	usd
CY2023	STRM	Increase In Valuation Allowance IncreaseInValuationAllowance	2029000	usd
CY2022	STRM	Increase In Valuation Allowance IncreaseInValuationAllowance	1950000	usd
CY2022	STRM	Income Tax Reconciliation Income Tax Expense Permanent Items Ppp Loan IncomeTaxReconciliationIncomeTaxExpensePermanentItemsPppLoan	-483000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	20000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	3000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	18000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-24000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-91000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-120000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	289000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-45000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-8000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	71000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	109000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	39000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	24000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	122000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	60000	usd
CY2023Q1	STRM	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities Current DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesCurrent	232000	usd
CY2022Q1	STRM	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities Current DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilitiesCurrent	168000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	11242000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	342000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	510000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1344000	usd
CY2023Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1407000	usd
CY2022Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1334000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	23000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	14730000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13027000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14347000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12318000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	383000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	709000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	5000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	6000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	482000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	798000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	487000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	804000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	104000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	95000	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	49884000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14347000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12318000	usd
CY2023	STRM	Increase In Valuation Allowance IncreaseInValuationAllowance	2029000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	333000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	315000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	315000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	315000	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	339000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	11000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	7000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	28000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	333000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	315000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	193000	usd
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65000000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2000000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	2000000	shares
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	65000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	85000000	shares
CY2023	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	two individual clients accounted for 10% or more of our continuing operations revenue.
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	258000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	188000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1062130	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.65
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M9D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	21000	usd
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.18
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	428172	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	3.68
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	628958	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.95
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M21D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	360000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	365069	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.36
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M19D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	628958	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.95
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M21D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	360000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	583333	shares
CY2022	STRM	Weighted Average Grant Date Fair Value Of Options Granted WeightedAverageGrantDateFairValueOfOptionsGranted	153	usd
CY2023Q1	STRM	Investment Ownership Percentage InvestmentOwnershipPercentage	0.20	pure
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	931125	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.0109
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1043350	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.0157
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1848031	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	0.0148
CY2020Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	12088000	usd
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	1130000	usd
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Prepaid And Other Assets DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssets	576000	usd
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Deferred Revenue DisposalGroupIncludingDiscontinuedOperationDeferredRevenue	4010000	usd
CY2020Q1	STRM	Disposal Group Including Discontinued Operation Net Tangible Assets Sold DisposalGroupIncludingDiscontinuedOperationNetTangibleAssetsSold	2304000	usd
CY2020Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	1772000	usd
CY2020Q1	us-gaap	Goodwill Goodwill	4825000	usd
CY2020Q1	STRM	Disposal Group Including Discontinued Operation Transaction Costs DisposalGroupIncludingDiscontinuedOperationTransactionCosts	1782000	usd
CY2020Q1	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	6013000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	498000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	5000	usd
CY2022	STRM	Transition Service Cost TransitionServiceCost	92000	usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	97000	usd
CY2022	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	401000	usd
CY2023	us-gaap	Payments For Rent PaymentsForRent	73000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	76000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	189000	usd
CY2023	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	-133000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	132000	usd
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	65000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	11000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	76000	usd
CY2023	dei	Auditor Firm AuditorFirmId	686

Files In Submission

Name	View Source	Status
0001493152-23-013852-index-headers.html	Edgar Link	pending
0001493152-23-013852-index.html	Edgar Link	pending
0001493152-23-013852.txt	Edgar Link	pending
0001493152-23-013852-xbrl.zip	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
strm-20230131.xsd	Edgar Link	pending
strm-20230131_def.xml	Edgar Link	unprocessable
strm-20230131_lab.xml	Edgar Link	unprocessable
strm-20230131_pre.xml	Edgar Link	unprocessable
strm-20230131_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$STRM
STREAMLINE HEALTH SOLUTIONS INC. Stock $strm

2023 Q2 Form 10-K Financial Statement

#000149315223013852 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRM STREAMLINE HEALTH SOLUTIONS INC. Stock $strm

2023 Q2 Form 10-K Financial Statement

#000149315223013852 Filed on April 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$STRM
STREAMLINE HEALTH SOLUTIONS INC. Stock $strm